Early outcomes in MDR-TB and XDR-TB patients treated with delamanid under compassionate use

Early data from the CU programme show delamanid may be effective in MDR/XDR-TB with few treatment options http://ow.ly/tA6Y30cs2Yg

Detalles Bibliográficos
Autores principales: Hafkin, Jeffrey, Hittel, Norbert, Martin, Alexandra, Gupta, Rajesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2017
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898945/
https://www.ncbi.nlm.nih.gov/pubmed/28751415
http://dx.doi.org/10.1183/13993003.00311-2017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5898945/
https://www.ncbi.nlm.nih.gov/pubmed/28751415
http://dx.doi.org/10.1183/13993003.00311-2017

Ejemplares similares